Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models.

L M Wakefield1, Y A Yang, O Dukhanina

  • 1Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, 41 Library DR MSC 5055, Bethesda, MD 20892, USA. wakefiel@dce41.nci.nih.gov

Breast Cancer Research : BCR
|March 16, 2001
PubMed
Summary

Transforming growth factor-beta (TGF-beta) shows promise as a breast cancer suppressor. Enhancing TGF-beta function could be a viable strategy for breast cancer chemoprevention.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clock Precision beyond the Standard Quantum Limit at 10^{-18} Level.

Physical review letters·2025
Same author

Measurement of the Electric Dipole Moment of ^{171}Yb Atoms in an Optical Dipole Trap.

Physical review letters·2022
Same author

First Report of Hop stunt viroid in Apricot in China.

Plant disease·2019
Same author

FOXA1 inhibits prostate cancer neuroendocrine differentiation.

Oncogene·2017
Same author

FOXA1 acts upstream of GATA2 and AR in hormonal regulation of gene expression.

Oncogene·2016
Same author

Oxidative stress contributes to the impaired sonic hedgehog pathway in type 1 diabetic mice with myocardial infarction.

Experimental and therapeutic medicine·2015

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Transforming growth factor-beta (TGF-beta) exhibits dual roles in cancer, acting as both a tumor suppressor and promoter.
  • Understanding TGF-beta's complex functions is crucial for developing effective breast cancer therapies.

Purpose of the Study:

  • To investigate the role of TGF-beta signaling in mammary gland tumorigenesis using genetically altered mouse models.
  • To explore the potential of TGF-beta pathway modulation for breast cancer chemoprevention.

Main Methods:

  • Utilized genetically engineered mouse models to study TGF-beta's in vivo effects on mammary gland development and tumorigenesis.
  • Analyzed the consequences of both TGF-beta overexpression and loss of TGF-beta response in the context of spontaneous and induced tumors.

Related Experiment Videos

Main Results:

  • Overexpression of TGF-beta suppressed mammary gland tumorigenesis, suggesting chemopreventive potential.
  • Loss of TGF-beta response correlated with increased mammary gland tumorigenesis, confirming its tumor suppressor activity.
  • Observed loss of TGF-beta receptors in human breast hyperplasias, indicating a potential role in tumor development.

Conclusions:

  • Endogenous TGF-beta signaling acts as a tumor suppressor in the mammary gland.
  • Targeting TGF-beta pathways may offer a novel approach for breast cancer chemoprevention.
  • Defects in TGF-beta receptor signaling could contribute to the pathogenesis of breast cancer.